Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Estrogen receptor α controls hair growth cycles and skin thickness in male mice.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

BMP signaling affects hair color by interacting with the MC-1R pathway.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Notch-related genes play a key role in the development and cycling of hair follicles.

AR polyglycine repeat doesn't cause baldness.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

PDGF signaling may play a role in hair growth cycle regulation.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Reduced AR gene methylation may cause early pubic hair growth in girls.

TRPV1 helps regulate hair growth cycles.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Cholesteatoma shows abnormal and increased EGF receptor expression, indicating its rapid growth.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Overexpression of the glucocorticoid receptor in mice causes developmental defects similar to ectodermal dysplasia.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.